Funder
National Institutes of Health
NCATS-University of Florida Clinical and Translational Science
PCORnet-OneFlorida
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Toxicology,Molecular Biology
Reference36 articles.
1. Siegel, R. L., Miller, K. D., & Jemal, A. (2016). Cancer statistics. CA: A Cancer Journal for Clinicians, 66, 7–30.
2. Chen, Z., & Ai, D. (2016). Cardiotoxicity associated with targeted cancer therapies. Molecular and Clinical Oncology, 4, 675–681.
3. Geisberg, C. A., & Sawyer, D. B. (2010). Mechanisms of anthracycline cardiotoxicity and strategies to decrease cardiac damage. Current Hypertension Reports, 12, 404–410.
4. Khan, A. A., Ashraf, A., Singh, R., Rahim, A., Rostom, W., Hussain, M., et al. (2017). Incidence, time of occurrence and response to heart failure therapy in patients with anthracycline cardiotoxicity. Internal Medicine Journal, 47, 104–109.
5. Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., et al. (2001). Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. New England Journal of Medicine, 344, 1031–1037.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献